Compounds > technetium
Page last updated: 2024-08-22

technetium and ER-Negative PR-Negative HER2-Negative Breast Cancer

technetium has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Song, N; Zhao, J; Zhao, L; Zhu, M1
Maaskant-Braat, AJG; Nieuwenhuijzen, GAP; Poodt, IGM; Schipper, RJ; Voogd, AC; Vugts, G1

Other Studies

2 other study(ies) available for technetium and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
    Contrast media & molecular imaging, 2019, Volume: 2019

    Topics: Animals; Biocompatible Materials; Carcinoma; Cell Line, Tumor; Drug Stability; Female; Fluorescein-5-isothiocyanate; Lymphatic Metastasis; Mammary Neoplasms, Animal; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Neoplasm Transplantation; Peptides, Cyclic; Radiopharmaceuticals; Random Allocation; Technetium; Tomography, Emission-Computed, Single-Photon; Triple Negative Breast Neoplasms

2019
Risk of Regional Recurrence After Negative Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence.
    Annals of surgical oncology, 2018, Volume: 25, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Axilla; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Risk Factors; Sentinel Lymph Node Biopsy; Technetium; Triple Negative Breast Neoplasms

2018